Skip to content

Homoeopathic Management of menopausal Symptoms.

An Interventional Study Using Individualized Homoeopathic Medicines With Miasmatic Approach in Management of Post-Menopausal Syndrome. A Single Arm Open Label study. - nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068464
Enrollment
30
Registered
2024-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N959- Unspecified menopausal and perimenopausal disorder

Interventions

Intervention1: Individualized Homoeopathic Medicines: Intervention- The individualized homoeopathic medicine will be selected according to the totality of symptoms. Dosage- Medicine will be given in

Sponsors

Dr Kanupriya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female patient who have attained menopause i.e. amenorrhea for last 12 consecutive months. 2. Female patient presenting with symptoms of Post-menopausal syndrome i.e. mood swings, hot flushes, insufficient sleep, and genitourinary problems/sexual dysfunction etc. 3. Diagnostic criteria are mainly on clinical presentation. 4. Females willing to participate in study and ready to provide informed written consent.

Exclusion criteria

Exclusion criteria: 1. Female patients who have undergone artificial menopause or surgical menopause and premature menopause. 2. Females suffering from any other systemic disorders such as diabetes mellitus, cardiac disorder, thyroid dysfunction and established case of mental illness etc. 3. Women having anti-depressents, HRT etc. or any other medication that may influence the outcome of study. 4. Patients with post-menopausal bleeding, malignancy and uterine fibroid. 5. Females not willing to participate in study. 6. Patients participating in any other ongoing study.

Design outcomes

Primary

MeasureTime frame
To identify the underlying prevalent miasm.Timepoint: 24 weeks

Secondary

MeasureTime frame
To compare the menopause rating scale at baseline and after 3 months to assess the utility of individualized homoeopathic medicine.Timepoint: 4 weeks, 12 weeks

Countries

India

Contacts

Public ContactDr Amitesh Kumar Singh

State National Homoeopathic Medical College And Hospital, 1-Viraj Khand, Gomti Nagar, Lucknow (UP)

dramitesh04@gmail.com8874073232

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026